EBS:NYSE
Emergent Biosolutions Inc
$6.91
0.00%
(0.00) 1D
$6.90
arrow_downward
-0.14% (-0.0100)bedtimeAfter hours
Closed: Oct 14, 4:00:03 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EBS...
Open
$6.87
High
$7.07
Low
$6.81
Mkt. cap
354.30M
Avg. vol.
1.14M
Volume
761.08K
52-wk high
$14.06
52-wk low
$4.36
EPS
-$3.51
Beta
2.28
Shares outstanding
51.27M
No. of employees
900
Open
$6.87
High
$7.07
Low
$6.81
Mkt. cap
354.30M
Avg. vol.
1.14M
Volume
761.08K
52-wk high
$14.06
52-wk low
$4.36
EPS
-$3.51
Beta
2.28
Shares outstanding
51.27M
No. of employees
900
News stories
From web sources and news partners
Yahoo
·
54 minutes ago
Dow closes in the red after report finds inflation rose in September
BigGo Finance
·
1 hour ago
U.S. Stocks: Nasdaq Tumbles 496 Points as September CPI Acceleration Reignites Rate-Hike Bets
WPTF
·
27 minutes ago
US stocks drop to their worst day since July as inflation worsens
TradingView
·
1 hour ago
The Dow Jones Index Closes 0.18% Lower
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
About Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Employees900
FoundedSep 5, 1998
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Websiteemergentbiosolutions.com